NL-OMON28646招募中不适用
Determination of protein profiles in vitreous of eyes with endophthalmitis with Surface Enhanced Laser desorption/ ionization time-of-flight (SELDI-tof) technology.
Drs. P.A.W.J.F. Schellekens. ophthalmologist0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 110
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with endophthalmitis:
- •1. Able to give informed consent;
排除标准
- •Endophthalmitis group:
- •1. Patients unable to give informed consent;
研究者
相似试验
已完成
不适用
Determination of protein profiles in vitreous of eyes with endophthalmitis with Surface Enhanced Laser desorption/ ionization time-of-flight (SELDI-tof) technology.Infection of vitreousinflammation of ocular fluid10021877NL-OMON33140niversitair Medisch Centrum Utrecht30
已完成
不适用
Proteomic analysis for establishing a biomarker panel for the onset of Adult T-cell Leukemia (ATL)JPRN-UMIN000038467niversity of the Ryukyus85
未知
Unknown
Measurement protein in biospecimens for wet AMDJPRN-jRCT1080223356Akita University, Jyusendo general Hospital, Tsukazaki hospital, Nagoya University, Gunma University40
进行中（未招募）
不适用
Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction - PROMETEODisfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension.EUCTR2008-001192-29-ESFundación Investigación y Desarrollo en el Area Cardiovascular
已完成
不适用
Identification and Semi -Quantification of ER/PR Proteins ExpressionBreast CancerNCT02654431Applied Spectral Imaging Ltd.350